Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Feb 1;205(3):266-267.
doi: 10.1164/rccm.202111-2663ED.

If All That You Have Is a Hammer…: Can We Phenotype Our Patients with Chronic Obstructive Pulmonary Disease?

Kenneth R Chapman  1   2
Affiliations
Editorial

If All That You Have Is a Hammer…: Can We Phenotype Our Patients with Chronic Obstructive Pulmonary Disease?

Kenneth R Chapman. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease.
    Ghosh AJ, Hobbs BD, Moll M, Saferali A, Boueiz A, Yun JH, Sciurba F, Barwick L, Limper AH, Flaherty K, Criner G, Brown KK, Wise R, Martinez FJ, Lomas D, Castaldi PJ, Carey VJ, DeMeo DL, Cho MH, Silverman EK, Hersh CP; COPDGene Investigators. Ghosh AJ, et al. Am J Respir Crit Care Med. 2022 Feb 1;205(3):313-323. doi: 10.1164/rccm.202106-1404OC. Am J Respir Crit Care Med. 2022. PMID: 34762809 Free PMC article.

References

    1. Tiffeneau R, Pinelli A. Circulating air and captive air in the exploration of the pulmonary ventilator function. Paris Med . 1947;37:624–628. - PubMed
    1. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis . 1987;136:225–244. - PubMed
    1. Jackevicius C, Joyce DP, Kesten S, Chapman KR. Prehospitalization inhaled corticosteroid use in patients with COPD or asthma. Chest . 1997;111:296–302. - PubMed
    1. Brusselle G, Price D, Gruffydd-Jones K, Miravitlles M, Keininger DL, Stewart R, et al. The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK. Int J Chron Obstruct Pulmon Dis . 2015;10:2207–2217. - PMC - PubMed
    1. Pavord ID, Menzies-Gow A, Buhl R, Chanez P, Dransfield M, Lugogo N, et al. Clinical development of mepolizumab for the treatment of severe eosinophilic asthma: on the path to personalized medicine. J Allergy Clin Immunol Pract . 2021;9:1121–1132.e7. - PubMed